Skin cancer is a common type of cancer that can occur anywhere on the body Read to find out about the least expected areas ...

In the following paper, we review the major malignant tumors of the ocular adnexa ... including squamous cell carcinoma and malignant melanoma. Immunotherapy with CD20 antibodies is a developing ...

There are several histopathologic variants of BCC, including the pigmented type, which contains melanin and thus can be confused with nevus or malignant melanoma. The eyelid defect created by ...

While melanoma is much less common than other types of skin cancer, it is the most serious because it is more likely to ...

Upon Opdualag’s approval in 2022 as a first-in-class cancer immunotherapy, Bristol Myers Squibb was anxious to explore its potential in a variety of indications. | Bristol Myers Squibb is striking out ...

The failure in adjuvant melanoma could cause BMS and Opdualag to miss out on a market opportunity that is nearly twice as large as its current approved indication, according to analysts.

Opdualag is a fixed-dose combination of nivolumab, a programmed death receptor-1 blocking antibody, and relatlimab, a lymphocyte activation gene 3 blocking antibody.

Bristol-Myers Squibb (NYSE:BMY) said that the Phase 3 RELATIVITY-098 study of its drug Opdualag in the treatment of late-stage melanoma didn't meet its primary endpoint. The drugmaker had been testing ...

The reality star, who was diagnosed with skin cancer in 2022, has now revealed that doctors have found multiple tumors on her ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

Jan. 27, 2025 — Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to ...

Feb. 7, 2025 — Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to ... Personalized Cancer ...